---
title: "What does low ferritin with normal haemoglobin mean?"
url: https://nutritailor.co.uk/apps/learn/what-does-low-ferritin-with-normal-haemoglobin-mean
slug: what-does-low-ferritin-with-normal-haemoglobin-mean
pillar: Iron
last_reviewed: 13 May 2026
confidence: mixed_evidence
publisher: "Nutri Tailor Health Reference Library"
editor: "Henry Bond"
---

# What does low ferritin with normal haemoglobin mean?

## Summary

Low ferritin with normal haemoglobin describes the early stage of iron deficiency before iron deficiency anaemia develops, frequently called iron deficiency without anaemia (IDWA). UK clinical practice (BSG 2021, NICE CKS) defines iron deficiency as ferritin below 30 µg/L. UK guidance does not specify a routine supplementation indication for IDWA; management is individualised. The integrative-style framing of 50-100 ng/mL functional optimal is not endorsed by BSG 2021 or NICE CKS outside RLS-specific subspecialty contexts.

## How it works

Camaschella 2015 (NEJM 372(19):1832-1843, PMID 25946282) and Camaschella 2019 (Blood 133(1):30-39, PMID 30401704) describe the staged model. Tissue iron-dependent processes (mitochondrial electron transport, thyroid peroxidase, dopamine synthesis via tyrosine hydroxylase) can be impaired before haemoglobin drops, which is the mechanistic basis for IDWA potentially producing symptoms before frank anaemia. Murray-Kolb 2007 (Am J Clin Nutr 85(3):778-787, PMID 17344500) showed reduced cognitive performance in young women with IDWA, with improvement on iron repletion.

## Effective dose

Moretti 2015 (Blood 126(17):1981-1989, PMID 26289639) demonstrated 60 mg elemental iron on consecutive days produced hepcidin elevations reducing absorption from the next dose by 35-45%. Stoffel 2017 (Lancet Haematol 4(11):e524-e533, PMID 29032957) and Stoffel 2020 (Haematologica 105(5):1232-1239) extended findings to alternate-day dosing in iron-deficient and iron-depleted women.

## Timing

If ferritin remains low despite adequate adherence, reconsider underlying cause workup. No specific ferritin target per BSG 2021; supplementation endpoint is clinical (resolution of symptoms or restoration of stores) rather than numerical. For IDA (low ferritin AND low Hb), continue oral iron 3 months after Hb normalisation per BSG 2021.

## Safety profile

Self-supplementation with iron without confirmed deficiency can be harmful, particularly in undiagnosed haemochromatosis (HFE C282Y homozygotes roughly 1 in 200 in UK Northern European populations) or other iron-loading conditions. Paediatric accidental ingestion is the standard reason iron supplements should be kept secured. Iatrogenic iron overload with long-term unsupervised supplementation is a documented risk. Inflammation must be excluded before interpreting ferritin: ferritin is an acute-phase reactant and rises in inflammation, infection, malignancy, liver disease, and obesity, independent of iron status (Camaschella 2019; Ganz 2019 NEJM 381(12):1148-1157, PMID 31532961).

## Special populations

Pregnancy: NICE NG201 antenatal care pathway covers screening and management. Athletes: AIS guidelines and recent reviews suggest more permissive supplementation thresholds in this group, though specific RCT evidence base is limited. RLS: AASM 2024 sets RLS-specific ferritin thresholds well above general iron deficiency cut-offs (75 µg/L or below for oral iron, 75-100 µg/L for IV iron). Frequent blood donors: post-donation iron replacement increasingly considered (Smith 2014 Cochrane CD009532; Pasricha 2017 Transfusion 57:1922-1929). Older adults: iron deficiency requires GI workup per BSG 2021 to exclude malignancy. Children: separate paediatric guidance applies.

## Interactions

The clinical evidence on iron repletion for fatigue in non-anaemic adults is mixed: positive in Verdon 2003 (BMJ 326(7399):1124, PMID 12763985) and Vaucher 2012 (CMAJ 184(11):1247-1254, PMID 22777991); negative in Keller 2020 (Sci Rep 10:14219, PMID 32848185); Krayenbuehl 2011 (Blood 118(12):3222-3227, PMID 21705493) showed benefit only in subgroup with ferritin 15 ng/mL or below. Dugan 2022 abridged Cochrane (J Cachexia Sarcopenia Muscle 13(6):2637-2649, PMID 36321348) reports SMD -0.30 (95% CI -0.52 to -0.09) with low to very low evidence quality across 21 RCTs and 3514 participants.

## Guideline positions

Ganz 2019 (NEJM 381(12):1148-1157, PMID 31532961) covers anaemia of inflammation. Verdon 2003, Vaucher 2012, Krayenbuehl 2011, Keller 2020, and Dugan 2022 form the IDWA-fatigue evidence chain. Murray-Kolb 2007 (Am J Clin Nutr 85(3):778-787, PMID 17344500) anchors the cognition signal. AASM 2024 (Winkelman et al, J Clin Sleep Med 21(1):137-152, PMID 39324694) sets the RLS-specific ferritin thresholds. The Stoffel/Moretti programme underpins the alternate-day dosing approach.

## Practical framework

GI investigation is indicated for unexplained iron deficiency in postmenopausal women and all men, even without anaemia, where occult GI bleeding (including malignancy) must be excluded. In premenopausal women, NICE NG88 heavy menstrual bleeding pathway is the leading underlying-cause workup. Supplementation in IDWA is more clearly indicated in: symptomatic patients (fatigue not explained otherwise, hair shedding, exercise intolerance, restless legs); RLS where guidelines specify higher ferritin targets; pregnancy planning; endurance athletes during heavy training; repeat blood donors with documented iron depletion. Failure to identify or address the underlying cause is the most common reason iron repletion fails. This is a summary of published research, not personal health advice. Discuss any health or supplement decisions with a qualified healthcare professional, particularly during ongoing care, pregnancy, or with chronic conditions.

## Common misconceptions

**Claim: a normal ferritin during inflammation reflects adequate iron stores.** Ferritin is an acute-phase reactant; CRP-paired interpretation is essential. In confirmed inflammation, alternative thresholds apply (some references use ferritin below 70 µg/L; TSAT below 16-20% is more reliable because TSAT is not an acute-phase reactant).

**Claim: switching between ferrous sulphate, fumarate, and gluconate for tolerability is evidence-supported.** BSG 2021 explicitly states it is not. The Tolkien 2015 meta-regression found no significant relationship between iron form and GI side-effect rate.

## Who this matters for

- Pregnancy
- Breastfeeding
- Adults over 65
- Post-menopause
- Perimenopause
- Endurance athletes
- Vegetarian diet
- Vegan diet
- Inflammatory bowel disease
- People taking levothyroxine

## Sources

1. Snook J, Bhala N, Beales ILP, Cannings D, Kightley C, Logan RPH, Pritchard DM, Sidhu R, Surgenor S, Thomas W, Verma AM (2021). British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults. Gut. PMID: 34497146. DOI: 10.1136/gutjnl-2021-325210.
2. NICE Clinical Knowledge Summary (CKS, UK government). Anaemia - iron deficiency. NICE Clinical Knowledge Summaries (CKS). https://cks.nice.org.uk/topics/anaemia-iron-deficiency/.
3. NICE (UK government). Heavy menstrual bleeding: assessment and management (NG88). National Institute for Health and Care Excellence (NICE). https://www.nice.org.uk/guidance/ng88.
4. Verdon F, Burnand B, Stubi CL, Bonard C, Graff M, Michaud A, Bischoff T, de Vevey M, Studer JP, Herzig L, Chapuis C, Tissot J, Pécoud A, Favrat B (2003). Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial. BMJ. PMID: 12763985. DOI: 10.1136/bmj.326.7399.1124.
5. Vaucher P, Druais P-L, Waldvogel S, Favrat B (2012). Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial. CMAJ. PMID: 22777991. DOI: 10.1503/cmaj.110950.
6. Krayenbuehl PA, Battegay E, Breymann C, Furrer J, Schulthess G (2011). Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration. Blood. PMID: 21705493. DOI: 10.1182/blood-2011-04-346304.
7. Keller P, von Kanel R, Hincapie CA, et al (2020). The effects of intravenous iron supplementation on fatigue and general health in non-anemic blood donors with iron deficiency: a randomized placebo-controlled superiority trial. Scientific Reports. PMID: 32848185. DOI: 10.1038/s41598-020-71048-0.
8. Dugan C, Cabolis K, Miles LF, Richards T (2022). Systematic review and meta-analysis of intravenous iron therapy for adults with non-anaemic iron deficiency: An abridged Cochrane review. Journal of Cachexia, Sarcopenia and Muscle. PMID: 36321348. DOI: 10.1002/jcsm.13114.
9. Murray-Kolb LE, Beard JL (2007). Iron treatment normalizes cognitive functioning in young women. American Journal of Clinical Nutrition. PMID: 17344500. DOI: 10.1093/ajcn/85.3.778.
10. Moretti D, Goede JS, Zeder C, Jiskra M, Chatzinakou V, Tjalsma H, Melse-Boonstra A, Brittenham G, Swinkels DW, Zimmermann MB (2015). Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood. PMID: 26289639. DOI: 10.1182/blood-2015-05-642223.
11. Stoffel NU, Cercamondi CI, Brittenham G, Zeder C, Geurts-Moespot AJ, Swinkels DW, Moretti D, Zimmermann MB (2017). Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. Lancet Haematology. PMID: 29032957. DOI: 10.1016/s2352-3026(17)30182-5.
12. Stoffel NU, von Siebenthal HK, Moretti D, Zimmermann MB (2020). Oral iron supplementation in iron-deficient women: how much and how often?. Molecular Aspects of Medicine. PMID: 32650997. DOI: 10.1016/j.mam.2020.100865.
13. Stoffel NU, Zeder C, Brittenham GM, Moretti D, Zimmermann MB (2020). Iron absorption from supplements is greater with alternate day than with consecutive day dosing in iron-deficient anemic women. Haematologica. PMID: 31413088. DOI: 10.3324/haematol.2019.220830.
14. Tolkien Z, Stecher L, Mander AP, Pereira DI, Powell JJ (2015). Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One. PMID: 25700159. DOI: 10.1371/journal.pone.0117383.
15. Winkelman JW, Berkowski JA, DelRosso LM, Koo BB, Scharf MT, Sharon D, Zak RS, Kazmi U, Falck-Ytter Y, Shelgikar AV, Trotti LM, Walters AS (2025). Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. PMID: 39324694. DOI: 10.5664/jcsm.11390.
16. Houston BL, Hurrie D, Graham J, et al (2018). Efficacy of iron supplementation on fatigue and physical capacity in non-anaemic iron-deficient adults: a systematic review of randomised controlled trials. BMJ Open. PMID: 29626044. DOI: 10.1136/bmjopen-2017-019240.